$0.9002
-0.0198[-2.15%]
Last update: 8:43AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$0.9002
0[0.00%]
| Open0.930 | Close0.920 |
| Vol / Avg.16.551K / 19.819K | Mkt Cap26.034M |
| Day Range0.920 - 0.950 | 52 Wk Range0.870 - 3.420 |
Candel Therapeutics Stock (NASDAQ:CADL), Key Statistics
Candel Therapeutics Stock (NASDAQ: CADL) analysis, key statistics.
Valuation Measures
Enterprise Value
-2.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
428.96
Price / Book (mrq)
0.86
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-121.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.06
Tangible Book value per share
1.06
Total Liabilities (Quarterly)
27.9M
Total Assets
58.7M
Total Liabilities
27.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Candel Therapeutics Stock (NASDAQ:CADL), Key Statistics
Candel Therapeutics Stock (NASDAQ: CADL) analysis, key statistics.
Valuation Measures
Enterprise Value
-2.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
428.96
Price / Book (mrq)
0.86
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-121.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.06
Tangible Book value per share
1.06
Total Liabilities (Quarterly)
27.9M
Total Assets
58.7M
Total Liabilities
27.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Candel Therapeutics Stock (NASDAQ:CADL), Key Statistics
Candel Therapeutics Stock (NASDAQ: CADL) analysis, key statistics.
Valuation Measures
Enterprise Value
-2.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
428.96
Price / Book (mrq)
0.86
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-121.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.06
Tangible Book value per share
1.06
Total Liabilities (Quarterly)
27.9M
Total Assets
58.7M
Total Liabilities
27.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Candel Therapeutics Stock (NASDAQ:CADL), Key Statistics
Candel Therapeutics Stock (NASDAQ: CADL) analysis, key statistics.
Valuation Measures
Enterprise Value
-2.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
428.96
Price / Book (mrq)
0.86
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-121.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.06
Tangible Book value per share
1.06
Total Liabilities (Quarterly)
27.9M
Total Assets
58.7M
Total Liabilities
27.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Candel Therapeutics Stock (NASDAQ:CADL), Key Statistics
Candel Therapeutics Stock (NASDAQ: CADL) analysis, key statistics.
Valuation Measures
Enterprise Value
-2.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
428.96
Price / Book (mrq)
0.86
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-121.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.06
Tangible Book value per share
1.06
Total Liabilities (Quarterly)
27.9M
Total Assets
58.7M
Total Liabilities
27.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Candel Therapeutics Stock (NASDAQ:CADL), Key Statistics
Candel Therapeutics Stock (NASDAQ: CADL) analysis, key statistics.
Valuation Measures
Enterprise Value
-2.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
428.96
Price / Book (mrq)
0.86
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-121.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.06
Tangible Book value per share
1.06
Total Liabilities (Quarterly)
27.9M
Total Assets
58.7M
Total Liabilities
27.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Candel Therapeutics Stock (NASDAQ:CADL), Key Statistics
Candel Therapeutics Stock (NASDAQ: CADL) analysis, key statistics.
Valuation Measures
Enterprise Value
-2.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
428.96
Price / Book (mrq)
0.86
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-121.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.06
Tangible Book value per share
1.06
Total Liabilities (Quarterly)
27.9M
Total Assets
58.7M
Total Liabilities
27.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Candel Therapeutics Stock (NASDAQ:CADL), Key Statistics
Candel Therapeutics Stock (NASDAQ: CADL) analysis, key statistics.
Valuation Measures
Enterprise Value
-2.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
428.96
Price / Book (mrq)
0.86
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-121.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.06
Tangible Book value per share
1.06
Total Liabilities (Quarterly)
27.9M
Total Assets
58.7M
Total Liabilities
27.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Candel Therapeutics Stock (NASDAQ:CADL), Key Statistics
Candel Therapeutics Stock (NASDAQ: CADL) analysis, key statistics.
Valuation Measures
Enterprise Value
-2.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
428.96
Price / Book (mrq)
0.86
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-121.74%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.06
Tangible Book value per share
1.06
Total Liabilities (Quarterly)
27.9M
Total Assets
58.7M
Total Liabilities
27.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -